Quantitative susceptibility mapping (QSM) and R2<sup>*</sup> of silent cerebral infarcts in sickle cell anemia.

Murdoch, Russell; Stotesbury, Hanne; Kawadler, Jamie M; Saunders, Dawn E; Kirkham, Fenella J; Shmueli, Karin

Quantitative susceptibility mapping (QSM) and R2^* of silent cerebral infarcts in sickle cell anemia.

Murdoch, Russell; Stotesbury, Hanne; Kawadler, Jamie M; Saunders, Dawn E; Kirkham, Fenella J; Shmueli, Karin.

Afiliação

Murdoch R; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Stotesbury H; Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Kawadler JM; Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Saunders DE; Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Kirkham FJ; Developmental Neurosciences, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
Shmueli K; University Hospital Southampton NHS Foundation Trust, and Clinical and Experimental Sciences, University of Southampton, Southampton, United Kingdom.

Front Neurol ; 13: 1000889, 2022.

Article em En | MEDLINE | ID: mdl-36341122

Palavras-chave

R2*; composition; infarction; magnetic susceptibility; quantitative susceptibility mapping (QSM); sickle cell anemia (SCA); silent cerebral infarction (SCI)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article